Prognostic impact of conventional cytogenetics in acute myeloid leukemia treated with venetoclax and decitabine.

ABSTRACT:

SUBMITTER: Venugopal S 

PROVIDER: S-EPMC10423012 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature